Hostname: page-component-54dcc4c588-smtgx Total loading time: 0 Render date: 2025-10-09T11:28:46.475Z Has data issue: false hasContentIssue false

Antimicrobial stewardship approach in reducing incidence of ESBL cases

Part of: APSIC 2024

Published online by Cambridge University Press:  03 September 2025

Lau Hui Shan
Affiliation:
Department of PharmacyHospital Wanita dan Kanak kanak, Sabah
Wong Ke Juin
Affiliation:
Infection control UnitHospital Wanita dan Kanak kanak, Sabah
Fong Siew Moy
Affiliation:
Infection control UnitHospital Wanita dan Kanak kanak, Sabah
Sandra Chew Bee Yian
Affiliation:
Infection control UnitHospital Wanita dan Kanak kanak, Sabah

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: With the increasing cases of multi-resistant organism infection, Antimicrobial Stewardship Programs (ASP) is an important tool in combating this rising challenges. The objective of this study is to review whether the approach of the reduction in usage of second and third generation cephalosporin group antibiotics reduces the incidence of ESBL E.coli and ESBL Klebsiella pneumoniae (KP) cases in Sabah Women and Children Hospital (SWACH) from 2021 until 2023. Methods: After discussion with the head of clinical services, the preferred empirical antibiotic of respective unit was switched to ampicilin-sulbactam or amoxicillin clavulanic acid instead of second or third generation cephalosporin. ASP team actively surveillant and monitored the above mentioned antibiotic, cephalosporin usage would be prescribed only to pre-determined indications, while others will be actively switched to ampicilin-sulbactam and amoxicilin- clavulanic acid. This study summarized the usage of Injection second and third generation of cephalosporin group antibiotics from year 2021 to year 2023 and compare with the incidence of ESBL cases per 100 patients admission during the same period. Usage of pediatric antibiotic described in number of vials over total number of admission, while adult antibiotic usage described in Defined daily dose (DDD). Occurrence of ESBL cases described in total number of cases/100 patient admission. The trend will then compared to the baseline ESBL E coli and KP in SWACH in the year prior this intervention. Results: For pediatric and adult O&G populations, we observed that the usage of overall cephalosporin group antibiotics showed a decreasing trend since year 2021 till year 2023 and a slight reduction in ESBL E coli and KP was observed at the same period. However, in adult oncology group, despite overall reduction in usage of cephalosporin group antibiotic except injection cefepime, the rate of ESBL E coli showed a slight increase. Conclusion: Coordinated efforts between stewardship programs and infection control are essential for reversing conditions that favor the emergence and dissemination of multidrug resistant gram negative bacteria within hospital.

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America